Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Zydus
FDA Approves GLYBURIDE AND METFORMIN HYDROCHLORIDE — Zydus Pharmaceuticals (USA) Inc.

Zydus Pharmaceuticals (USA) Inc. has received approval for its Abbreviated New Drug Application to market Glyburide and Metformin Hydrochloride, intro...

Pfizer
FDA Approves XELJANZ XR — Pfizer Laboratories Div Pfizer Inc

On February 23, 2016, the FDA granted approval to Pfizer's oral TOFACITINIB CITRATE for XELJANZ XR, marking a strategic expansion of the rheumatoid ar...

ScieGen
FDA Approves GABAPENTIN — ScieGen Pharmaceuticals, Inc.

# FDA Approves ScieGen Pharmaceuticals' Generic Gabapentin ScieGen Pharmaceuticals, Inc. received FDA approval for its generic gabapentin oral formul...

Sagent
FDA Approves FLUOROURACIL — Sagent Pharmaceuticals

# FDA Approves Sagent Pharmaceuticals' Generic Fluorouracil Injection Sagent Pharmaceuticals has received FDA approval for its generic fluorouracil i...

Amneal
FDA Approves DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Amneal Pharmaceuticals of New York LLC

Amneal Pharmaceuticals received FDA approval Wednesday for a supplemental ANDA to manufacture generic dexmethylphenidate (Ritalin La), an oral treatme...

ACCORD
FDA Approves Unknown Drug — ACCORD HLTHCARE

# FDA Approves ANDA Submission for Accord Healthcare Accord Healthcare has received FDA approval for its abbreviated new drug application (ANDA206058...

Creekwood
FDA Approves GABAPENTIN — Creekwood Pharmaceuticals LLC

# FDA Approves Generic Gabapentin from Creekwood Pharmaceuticals Creekwood Pharmaceuticals LLC has received FDA approval for its generic gabapentin o...

Sun
FDA Approves BUPRENORPHINE — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries, Inc. announced the approval of its generic buprenorphine hydrochloride sublingual tablets to market, providing a new af...

Eugia
FDA Approves TRANEXAMIC ACID — Eugia US LLC

Eugia US LLC received FDA approval for its ANDA for tranexamic acid intravenous injection (2016), a generic version of the marketed hemostatic agent. ...

CROSSMEDIKA
FDA Approves Unknown Drug — CROSSMEDIKA SA

Although specific details regarding the new application date are not provided, the filing of ANDA205348 by Crossmedika S.A. could potentially signal a...

Macleods
FDA Approves LEVOCETIRIZINE DIHYDROCHLORIDE — Macleods Pharmaceuticals Limited

# FDA Approves Macleods Pharmaceuticals' Generic Levocetirizine Dihydrochloride Macleods Pharmaceuticals Limited received FDA approval for its generi...

Amneal
FDA Approves VALSARTAN — Amneal Pharmaceuticals of New York LLC

Amneal Pharmaceuticals LLC announced the approval of its generic valsartan application (ANDA204011) on January 11, 2016, which is expected to broaden ...

MYLAN
FDA Approves Unknown Drug — MYLAN

Mylan has received regulatory approval from the FDA for a new generic product through ANDA 205257, signaling a potential new revenue opportunity for t...

Actelion
FDA Approves UPTRAVI — Actelion Pharmaceuticals US, Inc.

# FDA Approves Actelion Pharmaceuticals' UPTRAVI for Pulmonary Arterial Hypertension Actelion Pharmaceuticals US, Inc. received FDA approval for UPTR...

Lupin
FDA Approves MORPHINE SULFATE — Lupin Pharmaceuticals,Inc.

Lupin Pharmaceuticals, Inc. announced that the FDA approved its Abbreviated New Drug Application (ANDA) for Morphine Sulfate Oral Solution, offering a...

WG
FDA Approves AMPICILLIN AND SULBACTAM — WG Critical Care, LLC

WG Critical Care, LLC announces the FDA approval of their injectable generic ampicillin and sulbactam powder for intramuscular injection, supplementin...

Aurobindo
FDA Approves RISEDRONATE SODIUM — Aurobindo Pharma Limited

Aurobindo Pharma received FDA approval for its generic Risedronate Sodium oral tablets, opening a new revenue opportunity within the osteoporosis mark...

Accord
FDA Approves CLOZAPINE — Accord Healthcare Inc.

Accord Healthcare Inc. received FDA approval for generic CLOZAPINE, a move that expands supply for this crucial antipsychotic treatment and is expecte...

AstraZeneca
FDA Approves TAGRISSO — AstraZeneca Pharmaceuticals LP

AstraZeneca received FDA approval for TAGRISSO (osimertinib), enhancing its lung cancer portfolio and strengthening its position in the targeted thera...

ANI
FDA Approves DULOXETINE — ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. has announced the approval of the ANDA for duloxetine hydrochloride oral tablets, introducing a generic alternative to the b...